A 2OGD multi‐gene cluster encompasses functional and tissue specificity that direct furanocoumarin and pyranocoumarin biosynthesis in citrus
New Phytologist · 2025
DOI: 10.1111/nph.20322 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Phytologist, 2025. Verfasst von Livnat Goldenberg und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fruit Tree Sciences, The Volcani Center ARO, 68 HaMaccabim Road, Rishon LeZion, 7505101, Israel. Hauptthemen laut MEDLINE: Citrus, Furocoumarins, Multigene Family, Pyranocoumarins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Furanocoumarins (FCs) are plant defence compounds derived from the phenylpropanoid pathway via the coumarin umbelliferone that harbour some therapeutic benefits yet are the underlying cause of ‘grapefruit–drug interactions’ in humans. Most of the pathway genes have not been identified in citrus. We employed a genetic/Omics approach on citrus ancestral species and F1 populations of mandarin × grapefruit and mandarin × pummelo. Enzyme specificity was characterized by In vivo 2‐oxoglutarate‐dependent dioxygenase family (2OGD) activity assays. We identified a 2OGD multi‐gene cluster involved in coumarin/FC/pyranocoumarin biosynthesis; Species lacking FCs in leaves/fruit were homozygous for a 655‐base solo‐LTR frame‐disrupting insertion within one dual specificity C2′H/F6′H encoding 2OGD gene, demonstrating that integrity of this gene is fully correlated with the capacity to biosynthesize metabolites of the extended FC pathway in leaves/fruit. A second 2OGD is the prominent gene expressed in citrus roots, which contain a unique pattern of extended FC pathway metabolites, including the predominant pyranocoumarins. A third 2OGD gene encodes a single activity F6′H, which appears to be induced at the transcript level by citrus pathogens. The results provide insights into the genetic basis underlying the difference between citrus fruit FC producers (grapefruit and pummelo) and nonproducers (mandarin and orange) and provide a gene target to breed for FC‐free varieties by marker‐assisted breeding or genome editing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Fruit Tree Sciences, The Volcani Center ARO, 68 HaMaccabim Road, Rishon LeZion, 7505101, Israel.
- Department of Vegetable and Field Crops, The Volcani Center ARO, 68 HaMaccabim Road, Rishon LeZion, 7505101, Israel.
- Metabolomics Center, The Volcani Center ARO, 68 HaMaccabim Road, Rishon LeZion, 7505101, Israel.
ORCID-Profile: Livnat Goldenberg, Sandip Annasaheb Ghuge, Adi Doron-Faigenboim, Mira Carmeli-Weissberg, Felix Shaya, Ada Rozen, Yardena Dahan, Elena Plesser, Gilor Kelly, Yossi Yaniv, Tal Arad, Ron Ophir, Amir Sherman, Nir Carmi, Yoram Eyal
Zitieren
APA
Goldenberg, L., Ghuge, S. A., Doron-Faigenboim, A., Carmeli-Weissberg, M., Shaya, F., Rozen, A., Dahan, Y., Plesser, E., Kelly, G., Yaniv, Y., Arad, T., Ophir, R., Sherman, A., Carmi, N., & Eyal, Y. (2025). A 2OGD multi‐gene cluster encompasses functional and tissue specificity that direct furanocoumarin and pyranocoumarin biosynthesis in citrus. New Phytologist. https://doi.org/10.1111/nph.20322
Vancouver
Goldenberg L, Ghuge SA, Doron-Faigenboim A, Carmeli-Weissberg M, Shaya F, Rozen A, et al. A 2OGD multi‐gene cluster encompasses functional and tissue specificity that direct furanocoumarin and pyranocoumarin biosynthesis in citrus. New Phytologist. 2025. doi:10.1111/nph.20322
BibTeX
@article{Goldenberg2025,
author = {Goldenberg, Livnat and Ghuge, Sandip Annasaheb and Doron-Faigenboim, Adi and Carmeli-Weissberg, Mira and Shaya, Felix and Rozen, Ada and Dahan, Yardena and Plesser, Elena and Kelly, Gilor and Yaniv, Yossi and Arad, Tal and Ophir, Ron and Sherman, Amir and Carmi, Nir and Eyal, Yoram},
title = {A 2OGD multi‐gene cluster encompasses functional and tissue specificity that direct furanocoumarin and pyranocoumarin biosynthesis in citrus},
journal = {New Phytologist},
year = {2025},
doi = {10.1111/nph.20322}
}
EUVIMED